now detected with some frequency in patients with autism spectrum disorder through array comparative genomic hybridization [B-7, Shutske]. While, as noted above, this is becoming routine in clinical care, newly identified CNVs do not provide definitive confirmation of etiology; this therefore may simply compound the uncertainty that parents already feel about the potential severity and management challenges facing their children with autism spectrum disorder.
